Sionna Therapeutics, Inc. financial statements
Sionna Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 75.27M | 10-K |
| Cash and equivalents | USD 58.45M | 10-Q |
| Total debt | USD 8.68M | EODHD |
Sionna Therapeutics, Inc. financials on 6ix · Sionna Therapeutics, Inc. on 6ix